<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Susanne Somerville on Medium]]></title>
        <description><![CDATA[Stories by Susanne Somerville on Medium]]></description>
        <link>https://medium.com/@somerville_64843?source=rss-1bd2b766ae08------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*P9msZnQWCAyKEVf9FtXB0A.jpeg</url>
            <title>Stories by Susanne Somerville on Medium</title>
            <link>https://medium.com/@somerville_64843?source=rss-1bd2b766ae08------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 11:49:02 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@somerville_64843/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[MediLedger Network: How Blockchain-Enabled Solutions Will Change How Companies Do Business…]]></title>
            <link>https://medium.com/inside-chronicled/mediledger-network-how-blockchain-enabled-solutions-will-change-how-companies-do-business-667408158696?source=rss-1bd2b766ae08------2</link>
            <guid isPermaLink="false">https://medium.com/p/667408158696</guid>
            <category><![CDATA[pharmaceutical]]></category>
            <category><![CDATA[blockchain]]></category>
            <category><![CDATA[enterprise-blockchain]]></category>
            <category><![CDATA[life-sciences]]></category>
            <dc:creator><![CDATA[Susanne Somerville]]></dc:creator>
            <pubDate>Thu, 27 Aug 2020 18:11:07 GMT</pubDate>
            <atom:updated>2020-08-27T18:11:07.037Z</atom:updated>
            <content:encoded><![CDATA[<h3>MediLedger Network: How Blockchain-Enabled Solutions Will Change How Companies Do Business, Together</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*sDMhnkvOGQBk9e_vUZbGGA.png" /><figcaption>Business, Together</figcaption></figure><p>This month is the 4th anniversary of our very first industry group meeting of the <strong>MediLedger Project.</strong> The original goal was to bring leading life science innovators together to explore how blockchain could solve business problems and enable capabilities not possible with existing technology. Today we are the leading blockchain enterprise network in the Life Sciences industry. We already have a decentralized solution in production, and our second solution anticipates production transactions in the next few months. Our pipeline of future solutions is also growing rapidly. We are immensely proud of our industry partners for their vision and grateful that they trusted us to facilitate the industry conversations to get us here.</p><p>Despite great progress, I still feel blockchain and its capabilities are still not fully understood (or believed!). What has been missing until now is tangible, real-life examples of how this technology can be used to solve immediate business problems. I want to walk you through how we have enabled these capabilities in our solutions, and hope these examples can ignite the imagination of business leader’s to recognize pain points previously unaddressable until now.</p><h3>Solving Business Problems</h3><p>The <strong>MediLedger Network</strong> has been established with architecture and solution design that allow competitors and trading partners to sit in the same network, not controlled by any single party, and share data and transactions directly with each other without leaking any business intelligence. This innovative use of a set of cutting edge technologies enables capabilities not possible in standard on-prem or cloud-based solutions.</p><p>Chronicled has launched the first two solutions on the network to solve real business problems:</p><p>The <strong>Product Verification System</strong> enables Authorized Trading Partners (specifically licensed Wholesalers and Dispensers) to scan a barcode on prescription medicine, and get an answer back in less than a second from the Manufacturer’s database that the unique identifier is authentic. This solution provides a step-function improvement in drug security to reduce risk and fraud in the US medicine supply chain. This solution, built on industry-agreed standards enables interoperability with all solution providers, even those not in the MediLedger Network. The solution was initially designed to meet regulations around drugs returned and resold in the US. With the three big Wholesalers, as well as half of the top 20 Pharma Manufacturers using our solution, &gt; 95% of all drugs resold in the US will be verified with the MediLedger Network. We are now in discussion with Dispensers to enable sub-second verification at hospitals and pharmacies as well.</p><p>The <strong>Contract and Chargeback</strong> solution was designed to drastically reduce the disputes and revenue leakage in the current revenue management processes between Group Purchasing Organizations (GPOs), Manufacturers, and Wholesalers. The Life Science industry today has to manage &gt;100,000 disputes every day due to misaligned pricing and eligibility between parties. Data is continually changing: pricing updates; doctors and hospitals change business activities, potentially affecting their eligibility; changes in GPO and Wholesaler customers. Our solution, allowing companies to sit in a trusted network, ensures parties are connected both publicly and privately to ensure continuous alignment at all times, making all those disputes go away.</p><h3>Capabilities</h3><p>These two solutions are great case studies of many of the capabilities that become possible when the blockchain technology is incorporated into the solution design:</p><p><strong>Immutable Record Keeping</strong></p><p><strong><em>Capability: </em></strong>Having timestamped records of data, events, and transactions that can not be changed — even by the originator of the data — without everyone having both the original information and the evidence of changes made to the record.</p><p><strong><em>How:</em></strong> The MediLedger Network runs decentralized, so every participating company runs its infrastructure independently. All companies agree on network wide-rules, and the blockchain consensus enforces those rules. If the rules are met, all nodes record an identical record of the transaction. No one player can override or change any of the business rules or transaction records because the blockchain consensus prevents it.</p><p><strong><em>Examples: </em></strong>In our Contract and Chargeback solution, every time information about the contract is changed — new pricing, new eligibility, etc. — the Manufacturer puts an updated “proof” of the contract onto the blockchain. The Wholesaler knows that all chargebacks meeting the eligibility and price will be honored because the validity of that state of the contract can not be altered.</p><p>This construct can also be valuable in future interactions with agencies, like the FDA, where additional auditing can be eliminated as records associated with drug manufacturing or clinical trial data are stored in a state that is certified as not having been altered, while at the same time not sharing confidential information with parties who shouldn’t see it.</p><p><strong>Trusted Source of Truth</strong></p><p><strong><em>Capability:</em> </strong>Working from the same up-to-date data as your trading partners, guaranteed to come from the true source of the information.</p><p><strong><em>How:</em></strong> The MediLedger Network is permissioned, and so companies need to be onboarded based on the role they play in the process. The MediLedger solution ensures, through those company identities stored on the blockchain, that only they can add or modify information about their products or data via control of their company identity. By companies all participating securely in the same network, common data sharing becomes possible.</p><p><strong><em>Example</em></strong>: Our Product Verification solution is driven by the GS-1 product identifiers, Global Trade Identification Numbers (GTINs). By only allowing the licensed manufacturer to control that information, the other trading partners in the network can be assured that the information is coming from them.</p><p>In our Contract and Chargeback solution, we have enabled the sharing of Industry identifiers (HIBCC, HRSA, and DEA databases) so that everyone is operating off the same information. This enables real-time updating of any changes that can impact eligibility.</p><p><strong>Business Rule Enforcement</strong></p><p><strong><em>Capability:</em></strong> Ensuring all business rules that matter to you are enforced for any data or transactions prior to them being sent.</p><p><strong><em>How: </em></strong>“Smart Contracts” are logic that are stored on the blockchain, that no one independently can modify due to the decentralized nature of the solution (as described above about Immutable Records). This logic can ensure that the rules that have been agreed upon are enforced prior to allowing the data or transaction to be recorded.</p><p><strong><em>Example: </em></strong>As described above, the MediLedger Contract and Chargeback solution stores the latest state of the contract on the blockchain — all pricing and eligibility — in the form of a cryptographic proof, so no one can see the private information. When a Wholesaler goes to sell the product, they check against the blockchain that they are selling the drug at the current price and eligibility, and if not, the transaction will not be posted, and the chargeback will not be sent to the Manufacturer to accept. This, along with the immutable record, creates the incentive on both sides of the transaction: the manufacturer knows that their price/eligibility will be honored, and the wholesaler knows they will be paid.</p><p>Also, the Life Science industry (along with many others) relies on EDI infrastructure to exchange data and transactions between trading partners. EDI is simply a data exchange, with no rule enforcement or validation, that sends data in batches (not real-time) and relies on 3rd parties as intermediaries. The MediLedger Network enables rule enforcement and real-time exchanges directly between trading partners and is one of the core capabilities that will enable true automation between companies.</p><p><strong>Exchange of Digital IP</strong></p><p><strong><em>Capability:</em></strong> Having a trusted record of the transfer of ownership of products or IP between two parties.</p><p><strong><em>How: </em></strong>By setting up the appropriate business rules, we can ensure that only parties that have rights can control items, such as product identifiers or labeler codes, which includes transferring control of those items to other parties.</p><p><strong><em>Example</em></strong>: Our Product Verification solution has been designed with a smart contract that can allow the owner and controller of a molecule to transfer ownership of that molecule to another company (an M&amp;A scenario that is quite frequent in the Life Science industry). For example, if Pfizer is sells the ownership of a molecule to Novartis, they can initiate a transfer of the molecule on the blockchain, and Novartis can accept ownership on the blockchain. The packaging of the product will still have Pfizer identifiers for some time (packaging changes can take up to a year to be implemented), but the industry trading partners can understand that Novartis now has business responsibility for the molecule. In today’s world, this is often hard to decipher, as emails may not be interpreted as legal proof of the change. By the fact that the solution ensures only Pfizer can initiate the transfer, and only Novartis can initiate the receipt, the information can be trusted.</p><p>There are other capabilities that this network construct will enable that are not yet deployed in these two solutions, but are on our product roadmap for use in the near future:</p><p><strong>Trusted Multi-Party Conditional Logic</strong></p><p><strong><em>Capability: </em></strong>Based on a transaction between two parties, automatically trigger an event with a third party.</p><p><strong><em>How:</em></strong> Building off the logic of secure Business Rule Enforcement (see above), it will be easy to add additional logic to initiate a separate event/transaction with a separate third party.</p><p><strong><em>Example:</em></strong> In the near future, we intend to add automated GPO admin fee management built off the actual Chargeback transactions recorded on the blockchain between Wholesalers and Manufacturers.</p><p>We also see the potential to create a valuable data marketplace between companies. This exchange of data can trigger direct payments between trading partners, or other logic between parties directly or third parties that may have additional value-added activities associated with the data exchange.</p><p><strong>Digital Exchange of Credit</strong></p><p><strong><em>Capability: </em></strong>Similar to the Exchange of Assets, we can enable the direct peer-to-peer exchange of credit that can be automated and immutable between parties.</p><p><strong><em>How: </em></strong>By linking the network all the way through to companies’ actual bookkeeping ledgers, we can ensure the exchange of credits in a way that is immutable and trusted. Today’s world is run by double-entry accounting, allowing each party of a transaction to control their own ledger and source of the truth. In the future, this decentralized technology can allow for companies to securely share access to the <strong>same</strong> ledger — allowing them to trust the entries, and having them match every single time.</p><p><strong><em>Example: </em></strong>We have already begun to identify pain points between companies, where transaction reconciliation takes manual efforts due to invoices being grouped in different ways at each company. We have already started investigating how we can let computers do the work of identifying debits and credits at a chargeback level — and in the future at an individual saleable unit level — to ensure accurate bookkeeping every single time.</p><h3>What’s Next</h3><p>As companies and industries start to see the opportunities to solve difficult business problems the adoption of blockchain-powered solutions will grow. And as companies are connected in secure networks, the ability to combine data sets between companies in new ways will enable whole new ways of doing business. We are excited to be helping the industry see what is possible in the future of doing <strong>Business, Together</strong>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=667408158696" width="1" height="1" alt=""><hr><p><a href="https://medium.com/inside-chronicled/mediledger-network-how-blockchain-enabled-solutions-will-change-how-companies-do-business-667408158696">MediLedger Network: How Blockchain-Enabled Solutions Will Change How Companies Do Business…</a> was originally published in <a href="https://medium.com/inside-chronicled">Chronicled</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Preview: The Contracts and Chargebacks Solution on the MediLedger Network]]></title>
            <link>https://medium.com/inside-chronicled/preview-1-the-contracts-and-chargebacks-solution-on-the-mediledger-network-3ded67778071?source=rss-1bd2b766ae08------2</link>
            <guid isPermaLink="false">https://medium.com/p/3ded67778071</guid>
            <category><![CDATA[blockchain]]></category>
            <category><![CDATA[chargeback]]></category>
            <category><![CDATA[contract-management]]></category>
            <category><![CDATA[pharmaceutical]]></category>
            <category><![CDATA[mediledger]]></category>
            <dc:creator><![CDATA[Susanne Somerville]]></dc:creator>
            <pubDate>Thu, 02 Apr 2020 20:38:24 GMT</pubDate>
            <atom:updated>2022-11-03T17:48:59.038Z</atom:updated>
            <content:encoded><![CDATA[<p>In 2019, the <a href="https://www.prnewswire.com/news-releases/mediledger-product-verification-solution-has-launched-300879491.html">Product Verification System on MediLedger</a> was launched to enable the verification of saleable returned medicine in the US. This decentralized solution, powered by blockchain, has started the transformation of how companies in the Life Science industry will do business together. More than 95% of medication resold in the US will be verified on the MediLedger Network.</p><p>Today we are excited to share a brief preview of our newest commercial solution launching in 2021 on the MediLedger Network: <strong>Contracts &amp; Chargebacks. </strong>This solution is aimed at resolving chargeback disputes and streamlining pricing and service to hospitals, pharmacies and other medication dispensers.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*xDfKxI_-Lzcj86-g.png" /></figure><p>The sale and revenue realization of prescription medicine in this country is complicated. For pharmaceutical manufacturers, distributors and GPOs, the list of headaches is long: maintaining contract changes, determining customer eligibility, chargeback discrepancies, return discrepancies, etc. Companies have departments of heroic staff diligently making sure the data is up to date, the process runs as it is supposed to, and managing the dispute resolution where things didn’t line up. Industry estimates guess that 1–4% of a company’s revenue — <em>that is $5–20 Billion industry wide</em> — is being lost to leakage like incorrect pricing, duplicate chargebacks, omissions and mistakes. Who is winning? No one. And especially not the customer who often is subject to add-bills and re-bills.</p><blockquote><em>Industry estimates guess that 1–4% of a company’s revenue — that is $5–20 Billion industry wide — is being lost to leakage.</em></blockquote><p>We think we have created a better way.</p><p>With the Contracts and Chargeback solution on the MediLedger Network, we are connecting trading partners in a trusted network that ensures everyone can be aligned on the latest updates to customer or contract information, automating the analysis and impact of those updates, and ensuring the <strong><em>chargeback is accurate every time</em></strong>. No data needs to be shared with 3rd parties — all of the transactions take place between trading partners directly. Actually, you don’t even have to rely on your trading partners to do the process correctly — the system plays the role of adjudicator, and ensures the process runs correctly for every transaction. Every time.</p><p>We have been working with top manufacturers, distributors, and group purchasing organizations to understand the processes that take place <strong><em>between</em></strong> companies, and have developed a solution that solves everyone’s problems. <strong><em>A solution where everyone wins.</em></strong></p><p>With Contracts &amp; Chargebacks on MediLedger pharmaceutical manufacturers, distributors and GPOs can:</p><ol><li><strong>Enforce their Business Rules in their Partner’s Systems -</strong> Trading partners can enforce rules on transactions and information sent to them, so mistakes are fixed at the source.</li><li><strong>Rely on Industry Wide 3rd Party Data -</strong> Participants operate on the same data from HIBCC, DEA and other sources through integrations directly with the network.</li><li><strong>Map Customer ID Between Trading Partners -</strong> Manufacturers establish customer identity on MediLedger so partners have clarity on the customer being discussed.</li><li><strong>Automate Eligibility Determination - </strong>Manufacturer’s can automate contract eligibility utilizing integrated data assessed against their own eligibility rules.</li><li><strong>Auto-Adjudicate Chargeback Claims:</strong> Distributors always have valid, up-to-date customer pricing so chargeback claims are always valid</li><li><strong>Research with Historical Data: </strong>Historical data and research tools enable rapid resolution for rare disputes</li></ol><p>These benefits can create enormous value for all trading partners in the pharmaceutical industry and streamline pricing and service to dispensers.</p><h3>Where does that value come from?</h3><ul><li>Drastic <strong><em>reduction in disputes</em></strong> — and remaining disputes can be vetted quickly, bringing improved financial accuracy and potential reduction in corporate reserves</li><li><strong><em>Elimination of revenue leakage</em></strong> — everyone knows the process is working like it is supposed to</li><li>Better use of <strong><em>working capital and human resources</em></strong></li><li>Better customer experience — <strong><em>reduced add-bills and re-bills </em></strong>— and assurance they are getting the right price every time.</li></ul><p>The MediLedger Network is powered by blockchain, allowing the life science industry to operate in a connected, secure network and automate the business they do with each other. Contracts &amp; Chargebacks (CBK) is the solution built on MediLedger Network to eliminate disputes in the chargeback process by aligning customer, product and contract data between trading partners in real time. Let’s break down how this exciting solution works to show you the future of how companies do business together.</p><h3>The MediLedger Network — <a href="http://www.mediledger.com/">www.mediledger.com</a></h3><p>The solution starts with the permissioned MediLedger Network, where every company in the network is onboarded: identifying who they are, and then associating their industry identifiers with them and registering that identity on the blockchain. Through this onboarding, only legitimate businesses have access to the network, and companies know they can securely exchange information with their trading partners.</p><p>GPO rosters, customer eligibility, contract updates and other proprietary data is shared with necessary trading partners through the peer-to-peer network, where every participant has complete control over their data and nothing proprietary can be leaked. Public data from 3rd party sources (HIBCC, DEA, etc…), product data, and authorized participants in the network are stored on the blockchain where everyone has access and can operate on the same set of data as their partners.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*PlIfnRZPCBvtBGQ0.png" /><figcaption>Figure 1: The network has 2 paths where data and transactions can flow, the public blockchain network and the private peer-to-peer network. Every participant has one MediLedger Node that interfaces with both networks.</figcaption></figure><p>The key differentiation behind MediLedger is, through blockchain, the ability to enforce business rules on data and transactions before your trading partner sends them. For example in order for a new customer to be added to a GPO Roster it must meet the business rules established by a manufacturer.</p><blockquote><em>The key differentiation behind MediLedger is the ability to enforce business rules on data and transactions before your trading partner sends them.</em></blockquote><p>Validated data from trading partners means that internal automation can extend far beyond internal systems. MediLedger business rule enforcement eliminates disputes, ultimately streamlining and improving service to dispensers and patients.</p><p><a href="https://blog.chronicled.com/preview-2-the-workflow-with-contracts-chargebacks-on-the-mediledger-network-dca26471e9c9">Click here to read more about the step-by-step workflow through the MediLedger Network.</a></p><p>If you are interested in learning more email us at info@mediledger.com or go to <a href="https://www.chronicled.com/contact">Contact Us</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3ded67778071" width="1" height="1" alt=""><hr><p><a href="https://medium.com/inside-chronicled/preview-1-the-contracts-and-chargebacks-solution-on-the-mediledger-network-3ded67778071">Preview: The Contracts and Chargebacks Solution on the MediLedger Network</a> was originally published in <a href="https://medium.com/inside-chronicled">Chronicled</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Workflow for Contracts & Chargebacks on the MediLedger Network]]></title>
            <link>https://medium.com/inside-chronicled/preview-2-the-workflow-with-contracts-chargebacks-on-the-mediledger-network-dca26471e9c9?source=rss-1bd2b766ae08------2</link>
            <guid isPermaLink="false">https://medium.com/p/dca26471e9c9</guid>
            <category><![CDATA[contract-management]]></category>
            <category><![CDATA[pharmaceutical]]></category>
            <category><![CDATA[mediledger]]></category>
            <category><![CDATA[chargeback]]></category>
            <category><![CDATA[blockchain]]></category>
            <dc:creator><![CDATA[Susanne Somerville]]></dc:creator>
            <pubDate>Thu, 02 Apr 2020 20:35:19 GMT</pubDate>
            <atom:updated>2022-11-03T17:48:09.613Z</atom:updated>
            <content:encoded><![CDATA[<p><a href="https://blog.chronicled.com/preview-1-the-contracts-and-chargebacks-solution-on-the-mediledger-network-3ded67778071">In our first blogpost we provided an overview of the Contracts &amp; Chargebacks solution</a>. Here we walk through how the Contracts &amp; Chargebacks solution compliments the current industry process with data, updates and chargeback claims flowing through the MediLedger Network.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*NXtRdTL91L50ZCGSA252rA.jpeg" /></figure><h3>Step 1: GPO Roster Updates</h3><p>Roster updates are received real time by manufacturers and distributors, with agreed upon rules to ensure that the data is accurate and complete. Even if GPOs don’t participate, we can enable the upload of current rosters via CSV files to deliver the processing benefits to manufacturers and distributors.</p><p>Benefits:</p><ul><li>Cleaner data</li><li>Real time updates (vs biweekly)</li><li>Improved efficiency as roster upload and evaluation is automated</li></ul><h3>Step 2: Customer Mapping</h3><p>In our evaluation of the data used by the industry today, the only number that companies were confident never changed was companies’ own internal customer ID. We have set up evaluation rules to allow the manufacturer to define the customer, and then we connect the manufacturer to the appropriate distributor and GPO’s internal customer IDs ensuring they are referencing the same customer.</p><p>Benefits:</p><ul><li>Precise understanding that all trading partners are referencing the same customer</li><li>Reduced disputes, ability to more rapidly troubleshoot changes</li></ul><h3>Step 3: Customer Evaluation</h3><p>We have established linkages with all the associated databases that the industry uses today to evaluate customer eligibility: HIBCC, DEA, HRSA(340B), AHD, NPI. With all these linkages, the trading partners know that everyone is working off the same data at the same time; from this we have enabled rules engines that can execute each manufacturer’s unique eligibility evaluation, including Class of Trade assessment. This will also allow customers to be assigned to specific contracts as per the manufacturer’s rules, and all trading partners have visibility to those assessments, so any disagreements can be solved prior to any sales taking place.</p><p>Benefits:</p><ul><li>No data mismatches because everyone is working from the same data at the same time (not always true when companies update their core systems by themselves)</li><li>Manufacturer’s ability to vet the entire roster rather than just the customers that they have previously sold to before, decreasing risk for the distributors</li><li>Distributors efforts reduced by being able to reduce eligibility research</li></ul><h3>Step 4: Contract Updates</h3><p>Now the manufacturer can send updates, real time, to both the GPO and distributor, acting on all the updates, and subsequent impact on eligibility to provide the latest state of the contract: products, prices, and eligible customers. A cryptographic proof of the contract is then stored on the blockchain, which provides the trust between manufacturer and distributor, so that when the product is sold some time later to the customer, the manufacturer can know the right price and eligibility is being used.</p><p>Benefits:</p><ul><li>GPOs that have no visibility today can see latest eligibility of their customers to assist in troubleshooting or customer service</li><li>Everyone is updated real time with all updates incorporated</li><li>Everyone is working off the same data</li><li>The latest state of the contract is available to check against, without revealing any business intelligence to other network participants (i.e. pricing)</li><li>Can eliminate EDI 845</li></ul><h3>Step 5 &amp; 6: Chargeback Claims and Credit Transactions</h3><p>The distributor, upon sale of their product, can check the eligibility and price against the proof stored on the blockchain, knowing that if the Chargeback complies, it will automatically be approved by the manufacturer. The manufacturer knows they won’t receive chargebacks that don’t comply with the latest state of the contract, fully automating the process. The distributor can receive the credit transaction immediately.</p><p>Benefits:</p><ul><li>Enables full automation for the manufacturer — knows all chargebacks are accurate</li><li>Distributor knows they will get paid — can provide stability of financial plans, reduce reserves</li><li>Eliminates the EDI 844 and EDI 849</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*TwpxI0lvYGF5JUr6Gv85vA.png" /><figcaption>Figure 1: Contracts and Charegback Process. MediLedger Nodes easily integrate with current internal systems and processes, plugging in as a new sources of validated data and transactions for all partners</figcaption></figure><h3>Conclusions</h3><p>Using blockchain, we have enabled trading partners and competitors to sit in the same network, knowing they can all leverage the same solution while adopting the level of automation they are ready for. Distributors can especially benefit from running the same process for their suppliers, regardless of EDI adoption. We have also designed a deployment model making it easy to integrate with existing core systems, improving on existing investments, with a variety of adaptors to make integration as easy as possible.</p><p>We are bringing to market a comprehensive solution that solves a myriad of pain points this industry has suffered with for the last 20+ years. By leveraging modern technology we can now automate complex workflows, decision trees, and bespoke logic with a solution designed for both conservative and bold companies in the life science industry to easily adopt and deliver value to their customers and ultimately the patients we all serve.</p><p>If you are interested in learning more email us at info@mediledger.com or go to <a href="https://www.chronicled.com/contact">Contact Us</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=dca26471e9c9" width="1" height="1" alt=""><hr><p><a href="https://medium.com/inside-chronicled/preview-2-the-workflow-with-contracts-chargebacks-on-the-mediledger-network-dca26471e9c9">The Workflow for Contracts &amp; Chargebacks on the MediLedger Network</a> was originally published in <a href="https://medium.com/inside-chronicled">Chronicled</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Leading Chronicled: Blockchain in 2019]]></title>
            <link>https://medium.com/inside-chronicled/leading-chronicled-blockchain-in-2019-ad2e7861c862?source=rss-1bd2b766ae08------2</link>
            <guid isPermaLink="false">https://medium.com/p/ad2e7861c862</guid>
            <category><![CDATA[blockchain]]></category>
            <category><![CDATA[pharma]]></category>
            <category><![CDATA[mediledger]]></category>
            <dc:creator><![CDATA[Susanne Somerville]]></dc:creator>
            <pubDate>Fri, 18 Jan 2019 00:38:16 GMT</pubDate>
            <atom:updated>2020-05-15T00:39:10.897Z</atom:updated>
            <content:encoded><![CDATA[<p>2019 has just started, and is already preparing to be an exciting year. I want to share some reflections on the exciting work we are doing to bring blockchain based solutions to Life Science companies, and what lies ahead.</p><p>It is hard to imagine this all started just over two years ago. Eric Garvin and I, in the throes of helping companies get compliant with DSCSA regulations, sought out the appropriate partner to explore if blockchain could be a valuable technology to help bring the necessary interoperability to the industry. We joined the Chronicled team in 2017, and the combination of industry knowledge and blockchain expertise has proven a winning combination.</p><p>We have moved past the hype of blockchain to identify how to best use the technology to solve real business problems. Despite a lot of recent press espousing the decline of cryptocurrencies and blockchain, we only see exciting opportunities for the potential of this technology that allows trading partners and competitors to enforce cross-industry business rules in a trusted network.</p><p>With the closing of our Series A financing, we are looking ahead to the launch of commercial solutions in 2019. I am excited by this step of growth at the company with Ryan Orr stepping up from CEO to Chairman of Chronicled’s Board to continue driving our vision, and giving me the opportunity as CEO to ensure our success in Pharma while preparing for additional industry opportunities. Chronicled’s extraordinary team has delivered on the promise of what blockchain can do for industries, and as we grow the team we are excited to to not only deliver on the existing projects but also identify additional opportunities to create value for businesses in ways not possible with prior technology.</p><p>I’m excited to see how Chronicled will grow in this next phase and look forward to continuing to build upon our goal of delivering on the promise of blockchain.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-84zKCgYEFU1ynBRsOMW3A.jpeg" /></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ad2e7861c862" width="1" height="1" alt=""><hr><p><a href="https://medium.com/inside-chronicled/leading-chronicled-blockchain-in-2019-ad2e7861c862">Leading Chronicled: Blockchain in 2019</a> was originally published in <a href="https://medium.com/inside-chronicled">Chronicled</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[How To Establish Protocols Between Parties With Competing Interests]]></title>
            <link>https://medium.com/inside-chronicled/how-to-establish-protocols-between-parties-with-competing-interests-57b3185cf75d?source=rss-1bd2b766ae08------2</link>
            <guid isPermaLink="false">https://medium.com/p/57b3185cf75d</guid>
            <category><![CDATA[enterprise-technology]]></category>
            <category><![CDATA[protocol]]></category>
            <category><![CDATA[blockchain]]></category>
            <category><![CDATA[blockchain-technology]]></category>
            <category><![CDATA[consortium]]></category>
            <dc:creator><![CDATA[Susanne Somerville]]></dc:creator>
            <pubDate>Thu, 04 Oct 2018 14:01:02 GMT</pubDate>
            <atom:updated>2018-10-04T14:01:02.362Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*Z6mKK3PKRusPWqcjGjRhpA.jpeg" /></figure><p>We tend to take a lot of the rules we follow for granted.</p><p>When you hop in your car and head to the grocery store, you’re assuming that everyone else on the road is going to follow a set of protocols that keep drivers safe and traffic moving.</p><p>Without rules, picking up milk would suddenly become a dangerous and time-consuming adventure.</p><p>And protocols aren’t just for driving, either. Blockchain technology — and any company that uses it — also benefits from general rules that help people work together.</p><p>The problem is, just because you establish protocols, that doesn’t mean people will want to follow them.</p><blockquote>It’s difficult to get competing companies to use solutions in which everyone profits from the shared set of rules.</blockquote><p>As a solution provider, you have to be able to navigate companies or individuals who think a certain application will be better for their competitors or trading partners than it will be for them.</p><p>Here’s how you can do it:</p><h3><strong>Bring the argument up to a point of agreement.</strong></h3><p>It’s natural for companies to want a competitive advantage over others in their industry — and to be wary of anything that looks like it could give someone <em>else</em> an edge.</p><p>Most companies looking into blockchain solutions also want to gain an advantage from it, without seeing anyone else get ahead. And if you leave the argument at that level, consortiums will immediately stall. We’ve all been in situations where no one can move forward because of one intractable point that seemingly can’t be worked out.</p><blockquote><strong><em>When two parties disagree, you have to raise the argument until they can agree on something.</em></strong></blockquote><p>Say, for example, two people disagree on gun control measures. Can you get them to at least agree that they want to live in a safe society? Then, the conversation becomes more about how we can achieve that safety. Once you’ve broken the constraints and brought them to a higher level — one that supersedes their original argument — then you can begin proposing new ideas and solutions.</p><p>You’re simply elevating the conversation to find common ground to work from.</p><h3><strong>Experiment with protocols to ensure product-market fit.</strong></h3><p>So many companies with amazing products eventually fail because they lack a market, or couldn’t find the right market fit.</p><p>And honestly, that’s going to be an even greater challenge for blockchain companies than it is for your average startup. Nine out of 10 blockchain projects are estimated to be gone <a href="https://go.forrester.com/blogs/predictions-2018-the-blockchain-revolution-will-have-to-wait-a-little-longer/">by the end of 2018</a>. If that sounds crazy, then you may not have realized the explosion of projects and protocols in the industry of late.</p><p>The problem, of course, is that not all of these projects — or even most of them — are fueled by <a href="https://blog.chronicled.com/does-your-industry-need-blockchain-only-if-you-do-these-2-things-7cab01972298">a genuine market need</a> for what they’re providing.</p><blockquote>If you want to establish a lasting protocol that multiple parties can actually use, you must be in constant conversation about their different needs.</blockquote><p>You have to look at the issue from each party’s perspective and evaluate whether or not you’re providing something essential.</p><h3><strong>Establish the status quo to set the stage for industry standards.</strong></h3><p>Even <a href="https://blog.chronicled.com/how-blockchain-is-simplifying-pharmaceutical-track-and-trace-949ce4c37daa">in the pharmaceutical industry</a>, where regulations work to incentivize everyone, it’s still difficult to get all participants in a working group on board with a standard.</p><p>Let’s say that manufacturers want full visibility into their supply chains. But the status quo in the industry is privacy.</p><p>So, what’s the solution?</p><p>Maybe a protocol could create a situation where the manufacturer’s downstream trading partners are able to verify their drug is authentic — an enormous value when it comes to brand protection. The manufacturer won’t get the <a href="https://blog.chronicled.com/supply-chains-dont-want-total-data-transparency-here-s-what-will-work-instead-43e21c4106e">full, end-to-end visibility</a> they want, but this new status quo helps ensure brand security throughout the supply chain.</p><p>Sometimes, trade-offs will be sufficient. Other times, they may not be.</p><blockquote><strong><em>If you can establish a status quo that works well for multiple parties, then you have a chance at getting a large enough group to create a nucleus around that standard.</em></strong></blockquote><p>And in time, if the companies benefit, those standards will expand. Companies that may not have been okay with the trade-offs before may now see the benefit of working within this standard protocol.</p><p>That’s because everyone sits on a different continuum of change, so you have to be aware of that and factor it into your process.</p><p>Innovators and early adopters cannot drive the solutions you create toward their own interests. So you have to keep the people who aren’t in the room in mind. Because creating the initial protocols and the solution isn’t the end of the story.</p><p>The book on blockchain and establishing protocols has certainly not been written. And what we use it for today is a fraction of what we’ll be using it for once the technology is more established.</p><p><strong>Thank you for reading!</strong></p><p><strong>Want to learn more? Get in touch with the Chronicled team </strong><a href="https://chronicled.typeform.com/to/y80B2Y"><strong>here</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=57b3185cf75d" width="1" height="1" alt=""><hr><p><a href="https://medium.com/inside-chronicled/how-to-establish-protocols-between-parties-with-competing-interests-57b3185cf75d">How To Establish Protocols Between Parties With Competing Interests</a> was originally published in <a href="https://medium.com/inside-chronicled">Chronicled</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[3 Myths About Decentralized Distributed Blockchain Networks]]></title>
            <link>https://medium.com/inside-chronicled/3-myths-about-decentralized-distributed-blockchain-networks-3680325dd4b2?source=rss-1bd2b766ae08------2</link>
            <guid isPermaLink="false">https://medium.com/p/3680325dd4b2</guid>
            <category><![CDATA[supply-chain]]></category>
            <category><![CDATA[decentralized]]></category>
            <category><![CDATA[blockchain]]></category>
            <category><![CDATA[supply-chain-management]]></category>
            <category><![CDATA[blockchain-startup]]></category>
            <dc:creator><![CDATA[Susanne Somerville]]></dc:creator>
            <pubDate>Tue, 25 Sep 2018 18:51:36 GMT</pubDate>
            <atom:updated>2018-09-26T20:47:59.343Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*4eSjI_EkfwcG1G8RdFw4nQ.jpeg" /></figure><p>I’m a supply chain professional, in the strictest sense of the word “professional.” I’ve spent 15 years of my career developing a highly-refined sense for planning ahead, foreseeing risks, and developing plans to mitigate them.</p><p>I even have a “Your lack of planning is not my emergency!” t-shirt.</p><p>I’m trained to deal with reality, yet in the blockchain industry today, there’s a conspicuous lack of it in many of the “solutions” I hear about. The <a href="https://www.gartner.com/smarterwithgartner/5-trends-emerge-in-gartner-hype-cycle-for-emerging-technologies-2018/">Gartner Hype Curve</a> has blockchain falling fast, but there’s still plenty of snake oil to go around.</p><p>Personally, I don’t deal well with pipe dreams and hype being sold as real products and services.</p><p>The trouble is, when I meet new people at industry conferences, they often assume I’m one of the snake oil salesmen. People assume my team’s work is just another sham with a dubious white paper and no basis in reality.</p><p>That frustrates me, and make me a little sad, because our work revolves around two things: blockchain and integrity.</p><p>To share a little history and context, my team is working on the MediLedger Project — a blockchain network meant to serve the pharmaceutical industry. We’ve designed the network and associated protocols to meet the requirements of the Drug Supply Chain Security Act (DSCSA).</p><p>And while we’ve been successful in constructing a technical blockchain solution that meets the requirements of the DSCSA, we still have work to do in convincing people this isn’t just another over-marketed solution with nothing actually supporting it.</p><p>That said, there are three myths I continue to hear about networks like ours—and it’s time to address them.</p><h3><strong>1. A decentralized and distributed blockchain network isn’t essential.</strong></h3><p>Companies in the blockchain industry aspire for their solutions to be truly decentralized and distributed. And people outside the industry are still asking, “Okay, but why should I really care?”</p><p>The short answer is <a href="https://www.techopedia.com/definition/26802/vendor-lock-in">vendor lock-in.</a></p><p>When a system is distributed and decentralized, it reduces or eliminates that vendor lock-in. Right now the barrier to switching vendors is extremely high. So much money and effort has already been expended that companies are reluctant to switch — even if they’re unhappy with the service. But if everyone is following the same protocol, the cost to switch drops almost immediately, because everyone’s transacting on the same network.</p><p>You can think about it like email. In the early days, there were services that used to cost money and charge you based even on the number of emails you sent. Then, the free service Gmail came along. Suddenly, other providers had to compete, and money was no longer the deciding factor — the quality was.</p><blockquote>This focus on quality can happen in the pharmaceutical industry supply chain, but it’s going to take work.</blockquote><p>The trick here is that the blockchain provider and network participants all have to work together. One cannot benefit without the other. In fact, without cooperation, blockchain networks are no better than cloud services.</p><p>But all that cooperation leads me to the next myth I hear over and over.</p><h3><strong>2. Companies will have to share their data.</strong></h3><p>When we tell companies the solution will be distributed and decentralized, they immediately worry about their data.</p><p>Here’s the thing: if we want everyone in the industry to be in the network — competitors and trading partners with competing interests — then all the data on the blockchain has to be private. But for business rule enforcement in the smart contracts to work, all the transactions have to be on the blockchain instead of on private channels.</p><p>Initially, enterprises think this means they have to share their data with everyone else. That’s simply not true.</p><p>By using <a href="https://blog.chronicled.com/why-zk-snarks-are-crucial-for-blockchain-data-privacy-e02f4bc1d352">zero-knowledge proofs</a>, our team can obfuscate data, while still enforcing the rules. Everyone is able to operate within the same network and see all the network data, but individuals lack the ability to garner any business intelligence. Not even traffic patterns can be deciphered.</p><blockquote>All private data stays behind each company’s firewall, while the blockchain records transactions immutably and enforces business rules. No one has access to private data except the companies involved in the transaction.</blockquote><p>There is no “god mode,” no keys available for anyone to look at the data. Companies choose who to share data with, possibly monetizing information in a new way. But the choice is always in the hands of the network participants.</p><p>So to be clear, all blockchain data is visible to everyone — but it’s recorded in a way that it cannot convey any information. And all private data stays private behind companies’ firewalls, and no one has keys to access it except the company themselves.</p><p>That’s an important distinction, because not all blockchain networks are being set up this way.</p><h3><strong>3. The blockchain network developer is in control.</strong></h3><p>Many blockchain companies are setting up networks that sound great in theory but are really nothing more than the same cloud solutions enterprises already use. They control and run the software, and they have access to the data to mine as they see fit.</p><p>One has to ask critically how this is better than a central solution.</p><p>While the MediLedger Project will require a network manager to onboard people (everyone is identified — no anonymous participants) and ensure the network is running as it should, our partner Chronicled plays the role of the network manager. But the system is designed so that we don’t run any software. None. We created the protocols that everyone uses, but the industry controls it in truly distributed fashion.</p><p>That’s because our team wants to create protocols that people want to follow. We want to give the network control over the vendors they’re choosing and the protocols they want to participate in.</p><p>It puts choice and control in the customer’s hands.</p><p>We think that’s the future of business, and we want to be on the forefront of making it happen. Some people won’t believe it until it happens, but for those who can put aside the myths, the benefits will be incredible.</p><p><strong>Thank you for reading!</strong></p><p><strong>Want to learn more? Get in touch with the Chronicled team </strong><a href="https://chronicled.typeform.com/to/y80B2Y"><strong>here</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3680325dd4b2" width="1" height="1" alt=""><hr><p><a href="https://medium.com/inside-chronicled/3-myths-about-decentralized-distributed-blockchain-networks-3680325dd4b2">3 Myths About Decentralized Distributed Blockchain Networks</a> was originally published in <a href="https://medium.com/inside-chronicled">Chronicled</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why It’s Hard To Move From PoC To Commercial Solutions In Blockchain]]></title>
            <link>https://medium.com/inside-chronicled/why-its-hard-to-move-from-poc-to-commercial-solutions-in-blockchain-6b0b490f238?source=rss-1bd2b766ae08------2</link>
            <guid isPermaLink="false">https://medium.com/p/6b0b490f238</guid>
            <category><![CDATA[poc]]></category>
            <category><![CDATA[blockchain-application]]></category>
            <category><![CDATA[enterprise-technology]]></category>
            <category><![CDATA[blockchain-startup]]></category>
            <category><![CDATA[blockchain]]></category>
            <dc:creator><![CDATA[Susanne Somerville]]></dc:creator>
            <pubDate>Thu, 30 Aug 2018 16:30:10 GMT</pubDate>
            <atom:updated>2018-08-30T16:30:10.424Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*jw-11hyCV5fKcEweVXkYCQ.jpeg" /></figure><p>Many companies are focused on developing and operating blockchain networks. Some are focused on delivering the protocols for network participants that really solve their business problems.</p><p>But those protocols usually start as proofs of concept (PoC), since many are still trying to understand how to use this new technology.</p><p>Despite blockchain being in companies’ sights now for almost two years, there are still plenty of businesses out there trying new things, working on proofs of concept, and watching what others in the space are doing.</p><blockquote>And yet, the industry still isn’t seeing what one would think is a commensurate emergence of real commercial solutions.</blockquote><p>I have thought a lot about what stalls PoCs from moving from ideas to actual commercial implementations.</p><p>Here’s what I’ve noticed so far:</p><h3><strong>There are many different ways to use blockchain technology. Perhaps too many.</strong></h3><p>Blockchain is a complicated technology for those who don’t understand it. And even for those who do, reaching a consensus about how it should be used — and what it should be used for — is still a long ways off.</p><p>Just the other day, I was on a call with several people who have been in the blockchain industry for years. They’re more knowledgeable than most, but they still spent an hour debating about the best use case for a blockchain.</p><p>Part of the problem with these debates is that there often is no problem. What I mean is, it’s incredibly difficult to come up with a solution before you really know what you’re trying to solve. The technology may offer infinite innovative solutions, but you still have to start with a problem.</p><blockquote>Unfortunately, this problem-solution argument is creating a divide between the technologists and the business people within many companies.</blockquote><p>The technologists understand how blockchain can be used, and they’re excited to begin working with it. But they generally don’t understand business, which makes it difficult for them to know how a solution should be deployed to meet real business needs.</p><p>Continuous dialogue between both parties is the best way to solve this.</p><p><strong>Each side has to be willing to collaborate, assemble the necessary tools and capabilities, and then design the protocols they believe are the building blocks for a commercial solution.</strong></p><p>And that’s only one issue preventing these concepts from getting off the ground.</p><h3><strong>A lot of PoC’s use blockchain in a way that, upon completion, it was clear regular technology could have done the same thing.</strong></h3><p>Discovering new technology is always exciting. But there’s typically a divide between the people who understand it best and those who want to use it for anything and everything.</p><p>Companies are hungry to see how they can benefit from blockchain, and there are plenty of people who are eager to offer solutions.</p><p>Oftentimes, one or two companies create a PoC together with no real path forward. They then get stuck when turning the idea into an actual solution and driving adoption.</p><blockquote>Truthfully, you don’t need a blockchain solution for two parties working together. You can create a non-blockchain solution that has all the necessary capabilities.</blockquote><p>But you do need the blockchain if you’re planning on building a network.</p><p>If two parties create a blockchain-based solution, they’re usually doing it with the intention that many people will eventually use it. But therein lies the dilemma of blockchain PoCs. While it’s certainly easier to develop a solution among two parties, it’s unlikely anyone else will adopt the solution without an established network.</p><p>Once a network is created, the adoption of PoCs will rapidly accelerate because there’s a place for other solutions to land. There’s a built-in network to access and to sell the solution. I imagine we’ll see quick adoption once the first network and solution takes place.</p><p>We don’t know exactly how this will play out in the future.So we need discerning eyes, people who are ready to say, “We don’t need a blockchain for that.” And as industry PoCs continue to mature, we’ll also need people to say, “We need to get others involved if we’re going to turn this into an industry-wide solution.”</p><h3><strong>There are nuances to developing and adopting a working solution.</strong></h3><p>Everyone is still unclear on <a href="https://blog.chronicled.com/understanding-who-owns-a-permissioned-blockchain-bbfaee4dda0?source=user_profile---------2------------------&amp;gi=900fb78dd7b9">who owns a blockchain</a> and how that limits the benefits or usefulness of the technology.</p><p>This governance issue creates two major roadblocks for adoption.</p><p>With a technology this new, most companies are reticent to participate in a solution if they don’t know the technology and weren’t included in the creation process. We’ve seen some major corporations come out with blockchain supply chain solutions, but then have trouble finding anyone to use them. The simple reason for this is exclusion.</p><blockquote><strong><em>No one is eager to jump into the game if they didn’t help create the rules.</em></strong></blockquote><p>The other problem with commercial solution adoption is as old as time: people hardly agree on the best way to do things. For instance, some think HyperLedger is a better foundational blockchain. But others prefer Ethereum. There are a variety of ways to store and encrypt data, and while having plenty of options is nice, industries would benefit by having a standard protocol to follow.</p><p>The space just hasn’t settled down yet. We feel we have good traction in the pharmaceutical industry with our work on the MediLedger Project due to a focus on meeting regulatory requirements. But for other industries, it’s going to take more time before network norms emerge.</p><p>Until then, the best way to build the necessary networks is through inclusion, not exclusion. Invite potential future participants to have a say in the process.</p><p>The more people know and understand the rules, the more they’ll be willing to play. And hopefully, we’ll begin to see real solutions emerging from the sea of PoCs out there.</p><p><strong>Thank you for reading!</strong></p><p><strong>Want to learn more? Get in touch with the Chronicled team </strong><a href="https://chronicled.typeform.com/to/y80B2Y"><strong>here</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6b0b490f238" width="1" height="1" alt=""><hr><p><a href="https://medium.com/inside-chronicled/why-its-hard-to-move-from-poc-to-commercial-solutions-in-blockchain-6b0b490f238">Why It’s Hard To Move From PoC To Commercial Solutions In Blockchain</a> was originally published in <a href="https://medium.com/inside-chronicled">Chronicled</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Evolution Of Enterprise Blockchain And What Will Make The Technology Mainstream]]></title>
            <link>https://medium.com/inside-chronicled/the-evolution-of-enterprise-blockchain-and-what-will-make-the-technology-mainstream-2299777678ea?source=rss-1bd2b766ae08------2</link>
            <guid isPermaLink="false">https://medium.com/p/2299777678ea</guid>
            <category><![CDATA[blockchain-startup]]></category>
            <category><![CDATA[blockchain]]></category>
            <category><![CDATA[protocol]]></category>
            <category><![CDATA[enterprise]]></category>
            <category><![CDATA[enterprise-technology]]></category>
            <dc:creator><![CDATA[Susanne Somerville]]></dc:creator>
            <pubDate>Thu, 23 Aug 2018 14:35:00 GMT</pubDate>
            <atom:updated>2018-08-23T14:35:00.692Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*DBRiXyNZX5KOfBepJ03phA.jpeg" /></figure><p>In the fall of 2016, I attended a conference in Washington D.C. about blockchain and its implications for healthcare. It was hosted by The Office of the National Coordinator for Health Information Technology (ONC), and it was a first for the industry.</p><p>I remember there were a mix of people in the room — many with years of tech experience. But a lot of the attendees didn’t really understand what the blockchain could (or should) be used for.</p><p>The conversations were fairly confusing, not at all what you’d expect from a group with such experience.</p><p>And from the fall of 2016 to the beginning of 2017, it wasn’t easy to clear up misconceptions about the technology. There were no great articles out there explaining blockchain. In fact, most of the writing was dedicated to profiting from bitcoin.</p><p>Now, just a few years later, there are so many articles on the blockchain that it’s impossible for one person to read them all. That’s great news for the industry — and for people who want to learn about the technology.</p><p>Yet, there’s still an important piece of the puzzle missing.</p><blockquote>Most media has gotten really good at explaining how a blockchain works, but there’s still a gap when connecting it with appropriate use cases.</blockquote><p>If the industry wants the general public to adopt blockchain technology, helping people understand its specific uses is going to be essential.</p><p>Here’s why:</p><h3><strong>The idea of enterprise blockchain solutions is still relatively new.</strong></h3><p>I actually have emails saved from a working group I was a part of when blockchain was still relatively unknown in early 2017. We sent each other resources we thought would be helpful for understanding the technology.</p><p>I dug up those emails the other day to see how the conversations have changed, and I alternated between cringing and laughing.</p><p>For example, not that long ago, everyone was calling blockchain a <a href="http://www.cccinnovationcenter.com/challenges/block-chain-challenge/view-winners/">decentralized database</a>. But this past March, I went to a conference where every single speaker made a point to disabuse people of that notion.</p><blockquote>Everyone said the same thing, “We now know it’s not a database. It’s a distributed ledger.”</blockquote><p>Still, people hear what they want to hear. For instance, it’s not difficult to walk through one of the “<a href="https://blog.chronicled.com/does-your-industry-need-blockchain-only-if-you-do-these-2-things-7cab01972298">do you need a blockchain</a>” decision trees and come out on the other end believing you need a blockchain.</p><p>People want to use it, and that desire can color their vision.</p><p>Similarly, if you tell people a blockchain is a distributed ledger, some still think that means it’s a place to record data. And they would be partially correct. You can record data on a blockchain, but that’s not the use case that will ultimately drive adoption.</p><h3><strong>The desire for commercial solutions is growing.</strong></h3><p>Far more people understand the fundamentals of blockchain now than at this time last year, or the year before that.</p><p>But people need to transition from knowing the fundamentals to knowing what they can actually do with the technology. In reality, that’s a much more important aspect for helping the technology go mainstream.</p><p>Here’s another way to think about it. Personally, I don’t understand the technical details of how the internet works, but I don’t have to in order to make use of it. Blockchain is going to be the same way.</p><blockquote>People in the future likely won’t understand how a blockchain works, but they’ll know what to use it for.</blockquote><p>A good example of this is MediLedger’s <a href="https://blog.chronicled.com/how-blockchain-is-simplifying-pharmaceutical-track-and-trace-949ce4c37daa">blockchain solution for saleable returns</a> in the pharmaceutical industry. My team is using a blockchain to store the master data necessary to verify a product’s identity. The master data is public and available to everyone in the network, creating a single source of truth. Now, everyone can work from the same set of data rather than obtaining it independently — a system which often leads to errors and miscommunication.</p><p>Companies using the solution don’t necessarily need to know the underlying mechanics of how this process happens. But if they can understand how storing one set of master data on the blockchain is a valuable use case, they’re going to be more interested in investigating how it might help their business.</p><h3><strong>It will take specific enterprise solutions to make the technology mainstream.</strong></h3><p>The blockchain industry needs to have examples of actual commercial implementations if we want people to develop an understanding of what blockchain can be used for — and begin adopting it on a larger scale.</p><blockquote>Once those examples are available, there will be more “lightbulb” moments where companies realize the benefits of a commercial implementation.</blockquote><p>I think once the industry has five to ten stories of actual commercial solutions, then we’ll begin to see adoption accelerate. Executives will look at their own business, find the parallel, and replicate implementation based on what works best for their own enterprises.</p><p>There’s still a lot of hard detail work to be done, and realistically, the cycle from idea to potential commercial solution is still probably about two to three years away.</p><p>But once commercial applications start popping up, they’ll clarify what can actually be done — and spur more people to begin following by example.</p><p><strong>Thank you for reading!</strong></p><p><strong>Want to learn more? Get in touch with the Chronicled team </strong><a href="https://chronicled.typeform.com/to/y80B2Y"><strong>here</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2299777678ea" width="1" height="1" alt=""><hr><p><a href="https://medium.com/inside-chronicled/the-evolution-of-enterprise-blockchain-and-what-will-make-the-technology-mainstream-2299777678ea">The Evolution Of Enterprise Blockchain And What Will Make The Technology Mainstream</a> was originally published in <a href="https://medium.com/inside-chronicled">Chronicled</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Understanding Who Owns A Permissioned Blockchain]]></title>
            <link>https://medium.com/inside-chronicled/understanding-who-owns-a-permissioned-blockchain-bbfaee4dda0?source=rss-1bd2b766ae08------2</link>
            <guid isPermaLink="false">https://medium.com/p/bbfaee4dda0</guid>
            <category><![CDATA[blockchain-development]]></category>
            <category><![CDATA[industry]]></category>
            <category><![CDATA[blockchain]]></category>
            <category><![CDATA[enterprise-technology]]></category>
            <category><![CDATA[supply-chain]]></category>
            <dc:creator><![CDATA[Susanne Somerville]]></dc:creator>
            <pubDate>Fri, 13 Jul 2018 20:07:43 GMT</pubDate>
            <atom:updated>2018-07-13T20:07:43.433Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*-dfUlVGMuA1VDUtwvogTuw.jpeg" /></figure><p>I was at a conference the other week where people were discussing the creation of enterprise permissioned blockchain networks. And I kept hearing people say the same thing, “The technology is not the hard part. The governance is going to cause the most difficulty.”</p><blockquote><em>The issue they were referring to revolved around this question: Who should govern a permissioned blockchain system — one that’s distributed and as decentralized as possible — in a given industry?</em></blockquote><p>Ideally, it would be the participants (the industry themselves) who have control over their own network.</p><p>But there’s a paradox inherent in any system controlled entirely by the network participants: Industry players want to be involved in creating rules, building the network, and choosing how it’s operated, but don’t want to be held liable if something goes wrong.</p><p>So when trying to understand who truly should “own” a permissioned blockchain, we have to consider a few factors:</p><h3><strong>There are multiple players involved in each system.</strong></h3><p>First, you have the industry participants.</p><p>To use the pharma industry as an example, these would include manufacturers such as Pfizer, Merck, and Bayer, distributors like McKesson and Cardinal, and hospitals.</p><p>This industry can see the potential benefits of working together in a permissioned blockchain network to meet regulations and improve business operations, but they also have plenty of reservations. In a massive industry like pharma, a software glitch can be painful. It affects patients’ ability to access the medicine they need, and it can be costly.</p><p>The value of blockchain is that an industry ledger mirrored and synchronized across dozens of decentralized servers is far more resilient than a centralized system. However, if there is ever a problem with network capacity or performance, someone needs to be accountable. For many companies, taking on this liability is an unacceptable risk.</p><p>This is where software service providers come into the picture.</p><blockquote>Our vision is that the existing service providers who already offer solutions to the industry would run the network and support the permissioned blockchain.</blockquote><p>This would complement their existing services through the addition of a blockchain ledger, enforcement of business rules, and the connection to an industry network.</p><p>It would also provide easy access for pharma companies if the solution is set up as a new functionality of the existing systems. And as an additional opportunity for service providers to make revenue, it’s a win-win.</p><p>The final player in the system is a network manager. As decentralized as we would like to make this network, we think it’s crucial to have an entity watching to make sure the network is running as expected when handling critical operations such as shipping medicine. The network manager would have responsibilities like managing software upgrades, adding new smart contract functionality, ensuring the network capacity is sufficient as usage grows, and allowing access to the network.</p><p>If we start with an “industry first” principle, then there is room for the roles of each player to evolve. There are multiple scenarios that could happen, each involving different distribution of roles to individual parties.</p><h3><strong>The structures of these systems are moving towards two extremes.</strong></h3><p>On the one hand, we could have truly industry-led systems.</p><p>In these permissioned blockchain networks, the industry participants make the rules and call the shots. They pick the network manager they want to use, play an active role in the formation of the network, and have total control over the functionality implemented in the network.</p><p>This gives the industry full control over how the network serving the industry functions and meets their needs. The downside to this model is the industry has to agree on what functionality to allow. It might be difficult and time-consuming for competitors and trading partners to come to that agreement.</p><h4>Contrasting, we could have networks set up by a variety of commercial enterprises.</h4><p>These would be driven by the capitalistic forces of figuring out what the customer needs and delivering solutions to meet those needs.</p><p>Think of the Visa network. Participants can give feedback to the Visa, but they don’t have much of a say in the actual decision-making process. So if a company doesn’t like the credit card fees or perks associated with Visa, they will likely have to use another card.</p><p>In the pharmaceutical scenario, if the industry doesn’t get the services they are looking for from the network they’re using, they can switch to a different network. Or maybe they use a few networks for different business purposes: one for commercial drug movement, one for clinical studies, and so on.</p><p>Inevitably, specialization will emerge.</p><p>The problem with the enterprise model is that it encourages multiple ways to do the same thing, which causes multiple networks to emerge. This results in a process that is exactly contrary to creating standards and following the same protocols to drive efficiency across industries.</p><p>Those are the two bookends to governance, but they aren’t the only — or necessarily the best — options out there.</p><h3><strong>The ideal way to govern a permissioned system may be to meet somewhere in the middle.</strong></h3><p>Right now, industries are starting to talk about how to come together, how to create standards, and how to best set up coopetition for the future.</p><p>What we may see in the next few years is a convergence of the two structures of governance I mentioned earlier — industry-run and commercial entity-run — and the emergence of a hybrid that benefits all participants.</p><blockquote>If a network isn’t listening to what the industry needs or wants, it won’t be around very long.</blockquote><p>Still, there has to be an entity in place that can answer technical questions about what can actually be done with the network. Even if the industry wants to apply a certain set of rules, that doesn’t mean it’s feasible to architect them into the software running the system.</p><p>A hybrid system with network managers can help the industry distinguish between creative solutions that are possible and those that overreach.</p><p>No matter the structure, there needs to be a system of checks and balances between the governance of the system and the needs of the industry — especially since industries are beginning to organize themselves to take advantage of blockchain technology.</p><p>Startups like Chronicled are creating attractive solutions for permissioned blockchain networks. But these offerings are still in the early stages of exploration, and it isn’t entirely clear how industries and service providers will come together over the next few years.</p><p>For now, we can continue to build solutions and capabilities to serve industries while keeping these emerging dynamics in mind as we build and grow the networks.</p><p><strong>Thank you for reading!</strong></p><p><strong>Want to learn more? Get in touch with the Chronicled team </strong><a href="https://chronicled.typeform.com/to/y80B2Y"><strong>here</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=bbfaee4dda0" width="1" height="1" alt=""><hr><p><a href="https://medium.com/inside-chronicled/understanding-who-owns-a-permissioned-blockchain-bbfaee4dda0">Understanding Who Owns A Permissioned Blockchain</a> was originally published in <a href="https://medium.com/inside-chronicled">Chronicled</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Supply Chains Don’t Want Total Data Transparency. Here’s What Will Work Instead]]></title>
            <link>https://medium.com/inside-chronicled/supply-chains-dont-want-total-data-transparency-here-s-what-will-work-instead-43e21c4106e?source=rss-1bd2b766ae08------2</link>
            <guid isPermaLink="false">https://medium.com/p/43e21c4106e</guid>
            <category><![CDATA[data-privacy]]></category>
            <category><![CDATA[pharmaceuticals-industry]]></category>
            <category><![CDATA[supply-chain]]></category>
            <category><![CDATA[blockchain]]></category>
            <category><![CDATA[blockchain-startup]]></category>
            <dc:creator><![CDATA[Susanne Somerville]]></dc:creator>
            <pubDate>Tue, 08 May 2018 21:11:59 GMT</pubDate>
            <atom:updated>2018-05-08T21:11:59.671Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*gdguH-B6SHJS53L-esKpCg.jpeg" /></figure><p>Data transparency is a tricky subject.</p><p>When I present at pharma and blockchain conferences, people in the audience always ask me, “Why don’t you agree with total data transparency?”</p><p>After all, many believe complete transparency is the principal benefit of blockchain.</p><p>My answer is this: No industry will actually use a completely transparent supply chain blockchain-based solution.</p><blockquote>Total data transparency is generally anathema to companies with sensitive business intelligence.</blockquote><p>But let me expand on this, as there are a couple of factors necessary to understand.</p><h4><strong>First, for blockchain solutions to be immutable, they need to be distributed.</strong></h4><p>This means a range of players are operating the nodes of the network. In the case of the MediLedger Project — an open network solution for the pharmaceutical industry — our vision is for the nodes to be operated by companies in the industry that either participate in the prescription medicine supply chain or are key service providers serving the industry. Companies that have a stake in the success of the network and its function.</p><p>By operating those nodes, they have access to the data on the nodes. Because of this, there can be no relevant information discernible on the blockchain. Transactions can be stored (aka hashed) but if they are obfuscated in a way that business rules cannot be enforced, then value is lost. And there is additional information to be garnered just from traffic patterns.</p><h4><strong>Second, blockchain solutions will flourish if industries participate — specifically companies that overlap in their business relationships.</strong></h4><p>This means competitors who use the same vendors will be in the system together. If everyone is posting transactions, either directly or through a service provider, they have access to each other’s information.</p><p>Despite the clamor for utter transparency, we could use a healthy dose of caution. Implementing the blockchain across industries is going to take a realistic and open-minded approach.</p><h3><strong>A transparent blockchain network isn’t the ultimate solution for sharing data.</strong></h3><p>It’s usually wise to be wary of people who say they have a silver bullet for a complex problem.</p><p>It’s easy to say, “Why don’t I find a set of trusted people who are not in the industry, let them run the nodes, and promise not to share the information.”</p><p>I’m idealistic—but not that idealistic.</p><p>We live in a world where data is an incredibly valuable asset. Entire businesses revolve around collecting and selling data. And it’s naive to think companies will give up business intelligence just to use the blockchain.</p><blockquote>The fact is, many companies may not benefit from complete transparency.</blockquote><p>Today, a company sees all their own incoming and outgoing transactions. But they can’t see all of the transactions taking place along the supply chain.</p><p>If a supplier discovers where a company downstream is selling their products, they could potentially design a supply chain around that downstream company. They might develop a model that makes them irrelevant.</p><p>In the pharma industry, there’s a new regulation (the DSCSA) that is requiring the entire supply chain share data on an interoperable system. But not every industry has such regulations and rules that can align them. The challenge lies in getting many different parties to come together and agree to use the same network.</p><p>And radical data transparency just isn’t the best way to make that happen.</p><h3><strong>A trusted blockchain network can solve for data privacy issues.</strong></h3><p>So, businesses still want data privacy, potentially more so than they want to eliminate diversion and other unpleasantness in their supply chains.</p><p>That’s why at Chronicled we have created a system that enables both appropriate data privacy and “visibility” into the chain of custody. Using zero-knowledge proofs called zk-SNARKS, Chronicled came up with the MediLedger Project — a blockchain-based data privacy solution for the pharmaceutical supply chain. Utilizing business rule enforcement of smart contracts, coupled with the power of zero-knowledge proofs, companies can know that rules are being enforced without actually seeing the data.</p><blockquote>This solution doesn’t require participants to give up their privacy, but it does require them to work together in a network and standardize their processes.</blockquote><p>As more companies join the network, it becomes more useful by enforcing business rules, preventing diversion, and flagging counterfeit products. And the magic of zk-SNARKs that make it possible to do so without violating the business intelligence of the companies involved.</p><p>But all of this requires participants give up a certain measure of control to gain an overall advantage in their supply chains. The only way that will happen is if the benefits of the blockchain solution outweigh the concerns about data transparency.</p><h3><strong>The solution will evolve as the industry advances.</strong></h3><p>The blockchain industry is still in the early days of exploring the impact this technology will have on supply chain operations.</p><p>Our ideal solution is that everyone keeps their own data, decides when, with whom, and for how much value they are willing to share it. And part of this exploration is going to involve watching big ideas hit roadblocks.</p><p>Some participants want complete data transparency. Others don’t. You have to know what problem you want to solve, and identify what incentivizes (or de-incentivizes) everyone participating. Many people couldn’t even imagine solving problems like diversion without sharing any data.</p><p>That’s one of the most interesting and fun parts of working with a developing technology. You set off down a path and figure out how to solve problems as you go. Each problem you solve has the potential to create a new issue or new opportunity you didn’t foresee. Then, you have to refine ideas and create solutions you might not even have realized when you started.</p><p>Blockchain designs and solutions are still evolving, and it’s going to be very interesting to watch what data privacy solutions emerge as the industry advances.</p><p><strong>Want to learn more?</strong></p><p><strong>Get in touch with the Chronicled team </strong><a href="https://chronicled.typeform.com/to/y80B2Y"><strong>here</strong></a><strong>.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=43e21c4106e" width="1" height="1" alt=""><hr><p><a href="https://medium.com/inside-chronicled/supply-chains-dont-want-total-data-transparency-here-s-what-will-work-instead-43e21c4106e">Supply Chains Don’t Want Total Data Transparency. Here’s What Will Work Instead</a> was originally published in <a href="https://medium.com/inside-chronicled">Chronicled</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>